Experimental Factor Ontology (EFO) Information | |
Identifier | EFO_0002916 |
Description | Esophageal carcinoma (EC) is a tumor arising in the epithelial cells lining the esophagus and can be divided into two subtypes: esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC). [Orphanet: 70482] | Trait categories |
Cancer
Digestive system disorder
|
Synonyms |
14 synonyms
|
Mapped terms |
10 mapped terms
|
Child trait(s) | esophageal adenocarcinoma |
Polygenic Score ID & Name | PGS Publication ID (PGP) | Reported Trait | Mapped Trait(s) (Ontology) | Number of Variants |
Ancestry distribution GWAS Dev Eval |
Scoring File (FTP Link) |
---|---|---|---|---|---|---|
PGS002298 (PRS14_esophageal) |
PGP000328 | Choi J et al. Int J Cancer (2020) |
Esophageal cancer | esophageal carcinoma | 14 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002298/ScoringFiles/PGS002298.txt.gz |
PGS003387 (best_ESCA_BEEA) |
PGP000413 | Namba S et al. Cancer Res (2022) |
Esophageal adenocarcinoma or Barrett’s esophagus | Barrett's esophagus, esophageal adenocarcinoma |
601,980 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003387/ScoringFiles/PGS003387.txt.gz |
PGS003388 (best_ESCA_EA) |
PGP000413 | Namba S et al. Cancer Res (2022) |
Esophageal adenocarcinoma | esophageal adenocarcinoma | 356,743 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003388/ScoringFiles/PGS003388.txt.gz |
PGS Performance Metric ID (PPM) |
Evaluated Score |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|---|
PPM013027 | PGS002298 (PRS14_esophageal) |
PSS009661| European Ancestry| 406 individuals |
PGP000328 | Choi J et al. Int J Cancer (2020) |
Reported Trait: Esophageal cancer | — | AUROC: 0.53 [0.51, 0.56] | — | — | — |
PPM016262 | PGS003387 (best_ESCA_BEEA) |
PSS010077| European Ancestry| 270,026 individuals |
PGP000413 | Namba S et al. Cancer Res (2022) |
Reported Trait: esophageal adenocarcinoma | — | AUROC: 0.819 | R²: 0.0123 | age, sex, top 20 genetic principal components | — |
PPM016263 | PGS003388 (best_ESCA_EA) |
PSS010077| European Ancestry| 270,026 individuals |
PGP000413 | Namba S et al. Cancer Res (2022) |
Reported Trait: esophageal adenocarcinoma | — | AUROC: 0.814 | R²: 0.00875 | age, sex, top 20 genetic principal components | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS010077 | C15, histology was one of the followings: Adenocarcinoma, NOS; Adenocarcinoma, intestinal type; Adenocarcinoma in tubulovillous adenoma | — | [
|
— | European (British) |
— | UKB | Controls were samples without any cancer diagnosis or self-reported cancer |
PSS009661 | esophageal cancer (ICD-9 = 150 or ICD-10 = C15) | — | 406 individuals | — | European | — | UKB | — |